Creative Medical Technology Holdings, Inc. (CELZ) stock
Close on Nov 11, 2026Market cap $4.15MP/E –Yield –
Creative Medical Technology Holdings, Inc. saw revenue fall 50.0% to $3.00K over the twelve months to Sep 30, 2026. At the latest close the market valued the company at $4.15M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $4.15M
- P/E ratio
- –
- Price to sales
- 1383.78
- Price to book
- 0.60
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $3.00K
- Net income
- -$7.47M
- EPS, diluted
- -$1.98
- Book value per share
- $1.04
- Diluted shares
- 7M
Trading
- Previous close
- $0.60
- Open
- $0.60
- Day's range
- $0.60 – $0.65
- Volume
- 44,420
- Average volume (20 days)
- 106,382
- Beta (5 years)
- 1.57
- 52-week range
- $0.59 – $4.72
- RSI (14 days)
- 37.4
- Volatility (1 year)
- 142.1%
- Relative volume
- 0.01×
- WACC
- 12.7%
Market cap history
Month-end market cap since 2015, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | CELZ | S&P 500 | Difference | CELZ per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -24.9% | -2.4% | −22.5 pts | ||
| 3 months | -49.2% | -1.2% | −48.1 pts | ||
| Year to date | -67.9% | +12.3% | −80.2 pts | ||
| 1 year | -80.3% | +12.4% | −92.8 pts | ||
| 3 years | -85.2% | +78.8% | −164.0 pts | -47.1% | +21.4% |
| 5 years | -98.8% | +75.2% | −174.0 pts | -58.6% | +11.9% |
| 10 years | -100.0% | +311.1% | −411.1 pts | -73.6% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Press releases
Releases Creative Medical Technology filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- News
About Creative Medical Technology
Biological Products, (No Diagnostic Substances)
Creative Medical Technologies Holdings, Inc. is a commercial-stage biotechnology company focused on advancing regenerative therapies across immunotherapy, endocrinology, urology, neurology, and orthopedics. The company develops cell-based technologies and therapeutic platforms, notably ImmCelz, an autologous reprogrammed immune cell therapy, and AlloStem, an allogeneic human perinatal tissue-derived cell program. Its clinical and development pipeline targets multiple indications, including chronic lower back pain caused by degenerative disc disease, type 1 diabetes, female infertility, and erectile dysfunction. In addition, the enterprise pursues biodefense and therapeutic modeling initiatives that combine induced pluripotent stem cells with artificial intelligence. Its operations serve clinical trial populations and patients suffering from chronic, debilitating, or autoimmune conditions.
Company profile, executives and historyCreative Medical Technology stock: common questions
What is Creative Medical Technology's stock price?
CELZ closed at $0.63 on Nov 11, 2026, up 4.76% on the day. Over the past 52 weeks it traded between $0.59 and $4.72.
What is Creative Medical Technology's market cap?
Creative Medical Technology was worth $4.15M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is CELZ's P/E ratio?
Creative Medical Technology lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.98), so it has no meaningful P/E ratio.
How much revenue does Creative Medical Technology make?
Creative Medical Technology reported revenue of $3.00K for the twelve months to Sep 30, 2026, down 50.0% from a year earlier.
Does Creative Medical Technology pay a dividend?
No. Creative Medical Technology has not paid a cash dividend over the last twelve months.
How has CELZ stock performed over the past year?
Including dividends, CELZ returned -80.3% over the past year, against +12.4% for the S&P 500.
How many CELZ shares are sold short?
0M shares were sold short at the latest FINRA report, 1.19% of the float, or 1.0 days of average trading volume.
Who are Creative Medical Technology's competitors?
Companies most similar to Creative Medical Technology by business, industry and size include BCDA, ALLO, INMB, TCRT, SNTI.
See a number that looks wrong?